{
    "clinical_study": {
        "@rank": "48766", 
        "brief_summary": {
            "textblock": "The purpose of this study is to discuss whether the parturients who underwent elective\n      cesarean of such kind do not need prophylactic use of antibiotics and evaluate the risks and\n      economic benefits involved."
        }, 
        "brief_title": "no Antibiotics for Elective Cesarean With Low Risk of Infection", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Antibiotics , Elective Cesarean, China", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Elective cesarean\n\n          -  With normal temperature;\n\n          -  No signs of infection;\n\n          -  Normal degree of cleanliness in vaginal; .Normal amniotic fluid.\n\n        Exclusion Criteria:\n\n          -  Failure of vaginal delivery and emergency cesarean;\n\n          -  Premature rupture of membranes;\n\n          -  Antibiotics having been applied to 3 days before cesarean;\n\n          -  Having inflammation before cesarean: such as vaginitis, pelvic inflammatory disease,\n             chorioamnionitis;\n\n          -  Having infections in respiratory or urinary system before cesarean;\n\n          -  Placenta previa or placental abruption;\n\n          -  With medical and surgical complications;\n\n          -  BMI \u2265 30kg/m2;\n\n          -  Total blood loss more than 1000ml within 2 hours after cesarean"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "antibiotics group:202 none antibiotics group:212"
            }
        }, 
        "enrollment": {
            "#text": "212", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02126228", 
            "org_study_id": "2ndhsdu-ob"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "antibiotics, cesarean", 
        "lastchanged_date": "April 27, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jinan", 
                    "country": "China", 
                    "state": "Shandong", 
                    "zip": "250033"
                }, 
                "name": "2nd Hospital of Shandong University"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Randomized Controlled Trial on Antibiotics Application For Low Infection-risked Elective Cesarean", 
        "other_outcome": {
            "description": "Incision healing;Intrauterine infection;Pelvic and abdominal infection;Infection of urinary system", 
            "measure": "Observation of puerperal infection", 
            "safety_issue": "Yes", 
            "time_frame": "30days"
        }, 
        "overall_official": {
            "affiliation": "Obstetrics of 2nd Hospital of Shandong University", 
            "last_name": "YONGPING XU, MD.PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Temperature", 
            "safety_issue": "Yes", 
            "time_frame": "3days"
        }, 
        "reference": {
            "PMID": "20733474", 
            "citation": "Committee opinion no. 465: antimicrobial prophylaxis for cesarean delivery: timing of administration. Obstet Gynecol. 2010 Sep;116(3):791-2. doi: 10.1097/AOG.0b013e3181f68086."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02126228"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shandong University", 
            "investigator_full_name": "Fanzhen Hong", 
            "investigator_title": "Obstetrics of 2nd Hopital", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Postpartum hemorrhage volume estimates and Routine blood test.", 
            "safety_issue": "Yes", 
            "time_frame": "3days"
        }, 
        "source": "Shandong University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fanzhen Hong", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Month", 
        "verification_date": "April 2014"
    }
}